FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2892367859> ?p ?o ?g. }

• W2892367859 abstract "Purpose To estimate the incidence of late-occurring venous thromboembolism (VTE) among survivors of childhood cancer and to identify risk factors for VTE to facilitate diagnosis and prevention. Methods The Childhood Cancer Survivor Study is a multi-institutional cohort of 24,355 5-year childhood cancer survivors (diagnosed between 1970 and 1999; median age at last follow-up, 28.7 years [range, 5.6 to 58.9 years]; median follow-up since diagnosis, 21.3 years [range, 5.0 to 39.2 years]) and 5,051 sibling participants. The primary end point was self-reported late (≥ 5 years after cancer diagnosis) VTE. Rate ratios (RRs) were estimated with multivariable piecewise exponential models. Results Late VTE incidence among survivors and siblings was 1.1 and 0.5 events per 1,000 person-years, respectively (RR, 2.2; 95% CI, 1.7 to 2.8), with 2.5 excess events per 100 survivors over 35 years. Among survivors, risk factors for VTE were female sex (RR, 1.3; 95% CI, 1.1 to 1.6), cisplatin (reference none; 1 to 199 mg/m 2 : RR, 3.0 [95% CI, 1.4 to 6.5]; 200 to 399 mg/m 2 : RR, 1.9 [95% CI, 1.0 to 3.6]; ≥ 400 mg/m 2 : RR, 2.0 [95% CI, 1.2 to 3.3]), l-asparaginase (RR, 1.3; 95% CI, 1.0 to 1.7), obesity or underweight (reference body mass index [BMI] 18.5 to 24.9 kg/m 2 ; BMI ≥ 30.0 kg/m 2 : RR, 1.6 [95% CI, 1.2 to 2.0]; BMI < 18.5 kg/m 2 : RR, 2.4 [95% CI, 1.7 to 3.4]), and late cancer recurrence or subsequent malignant neoplasm (RR, 4.6; 95% CI, 3.6 to 5.8). Among lower-extremity osteosarcoma survivors, limb salvage (reference amputation; RR, 3.1; 95% CI, 1.2 to 7.5) and cisplatin 200 to 399 or ≥ 400 mg/m 2 (reference none; RR, 4.0 [95% CI, 1.1 to 14.6] and 2.9 [95% CI, 1.1 to 8.0], respectively) were independently associated with late VTE. VTE was associated with increased risk for nonexternal cause late mortality (RR, 1.9; 95% CI, 1.6 to 2.3). Conclusion Childhood cancer survivors are at increased risk for VTE across their lifespan and a diagnosis of VTE increases mortality risk. Interventions that target potentially modifiable comorbidities, such as obesity, warrant consideration, with prophylaxis for high-risk survivors, including those treated with cisplatin and limb-sparing approaches." @default.
• W2892367859 created "2018-09-27" @default.
• W2892367859 creator A5001530469 @default.
• W2892367859 creator A5008672006 @default.
• W2892367859 creator A5010260826 @default.
• W2892367859 creator A5016016418 @default.
• W2892367859 creator A5018600971 @default.
• W2892367859 creator A5037740620 @default.
• W2892367859 creator A5038361086 @default.
• W2892367859 creator A5055171297 @default.
• W2892367859 creator A5065573166 @default.
• W2892367859 creator A5066629883 @default.
• W2892367859 creator A5071526115 @default.
• W2892367859 creator A5071930615 @default.
• W2892367859 creator A5078465445 @default.
• W2892367859 creator A5085028455 @default.
• W2892367859 date "2018-11-01" @default.
• W2892367859 modified "2023-10-02" @default.
• W2892367859 title "Long-Term Risk of Venous Thromboembolism in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study" @default.
• W2892367859 cites W106352447 @default.
• W2892367859 cites W1131015533 @default.
• W2892367859 cites W1187335281 @default.
• W2892367859 cites W1225261748 @default.
• W2892367859 cites W1924761337 @default.
• W2892367859 cites W1988228415 @default.
• W2892367859 cites W2015758016 @default.
• W2892367859 cites W2023234945 @default.
• W2892367859 cites W2028156044 @default.
• W2892367859 cites W2035056966 @default.
• W2892367859 cites W2041344443 @default.
• W2892367859 cites W2043103956 @default.
• W2892367859 cites W2057260087 @default.
• W2892367859 cites W2058217833 @default.
• W2892367859 cites W2065443310 @default.
• W2892367859 cites W2101807916 @default.
• W2892367859 cites W2102967512 @default.
• W2892367859 cites W2110992040 @default.
• W2892367859 cites W2111448024 @default.
• W2892367859 cites W2114788594 @default.
• W2892367859 cites W2118604325 @default.
• W2892367859 cites W2121411489 @default.
• W2892367859 cites W2144410376 @default.
• W2892367859 cites W2158143959 @default.
• W2892367859 cites W2162039240 @default.
• W2892367859 cites W2169002239 @default.
• W2892367859 cites W2179164822 @default.
• W2892367859 cites W2323716083 @default.
• W2892367859 cites W2332736166 @default.
• W2892367859 cites W2480680997 @default.
• W2892367859 cites W2527323727 @default.
• W2892367859 cites W2577748415 @default.
• W2892367859 cites W2746148189 @default.
• W2892367859 cites W2752414510 @default.
• W2892367859 doi "https://doi.org/10.1200/jco.2018.78.4595" @default.
• W2892367859 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30216123" @default.
• W2892367859 hasPublicationYear "2018" @default.
• W2892367859 type Work @default.
• W2892367859 sameAs 2892367859 @default.
• W2892367859 citedByCount "9" @default.
• W2892367859 countsByYear W28923678592019 @default.
• W2892367859 countsByYear W28923678592020 @default.
• W2892367859 countsByYear W28923678592021 @default.
• W2892367859 countsByYear W28923678592022 @default.
• W2892367859 countsByYear W28923678592023 @default.
• W2892367859 crossrefType "journal-article" @default.
• W2892367859 hasAuthorship W2892367859A5001530469 @default.
• W2892367859 hasAuthorship W2892367859A5008672006 @default.
• W2892367859 hasAuthorship W2892367859A5010260826 @default.
• W2892367859 hasAuthorship W2892367859A5016016418 @default.
• W2892367859 hasAuthorship W2892367859A5018600971 @default.
• W2892367859 hasAuthorship W2892367859A5037740620 @default.
• W2892367859 hasAuthorship W2892367859A5038361086 @default.
• W2892367859 hasAuthorship W2892367859A5055171297 @default.
• W2892367859 hasAuthorship W2892367859A5065573166 @default.
• W2892367859 hasAuthorship W2892367859A5066629883 @default.
• W2892367859 hasAuthorship W2892367859A5071526115 @default.
• W2892367859 hasAuthorship W2892367859A5071930615 @default.
• W2892367859 hasAuthorship W2892367859A5078465445 @default.
• W2892367859 hasAuthorship W2892367859A5085028455 @default.
• W2892367859 hasConcept C120665830 @default.
• W2892367859 hasConcept C121332964 @default.
• W2892367859 hasConcept C121608353 @default.
• W2892367859 hasConcept C126322002 @default.
• W2892367859 hasConcept C141071460 @default.
• W2892367859 hasConcept C187212893 @default.
• W2892367859 hasConcept C2780221984 @default.
• W2892367859 hasConcept C2780586474 @default.
• W2892367859 hasConcept C2781121325 @default.
• W2892367859 hasConcept C44249647 @default.
• W2892367859 hasConcept C61511704 @default.
• W2892367859 hasConcept C71924100 @default.
• W2892367859 hasConcept C72563966 @default.
• W2892367859 hasConcept C82789193 @default.
• W2892367859 hasConceptScore W2892367859C120665830 @default.
• W2892367859 hasConceptScore W2892367859C121332964 @default.
• W2892367859 hasConceptScore W2892367859C121608353 @default.
• W2892367859 hasConceptScore W2892367859C126322002 @default.
• W2892367859 hasConceptScore W2892367859C141071460 @default.
• W2892367859 hasConceptScore W2892367859C187212893 @default.
• W2892367859 hasConceptScore W2892367859C2780221984 @default.

• next